Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORITAVANCIN vs OSELTAMIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORITAVANCIN vs OSELTAMIVIR: Safety Overview

Metric ORITAVANCIN OSELTAMIVIR
Total FAERS Reports 884 11,686
Deaths Reported 29 1,045
Death Rate 3.3% 8.9%
Hospitalizations 157 2,284
Average Patient Age 55.9 yrs 42.4 yrs
% Female Patients 52.2% 54.2%
FDA Approval Date N/A Aug 3, 2016
Manufacturer Melinta Therapeutics, LLC Proficient Rx LP
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription